Skip to main content
Clinical Trials/NCT02970357
NCT02970357
Completed
Not Applicable

Evaluation of the Impact of a Therapeutic Education Program for Children With Type 1 Diabetes. A French Monocentric Prospective Study. Pilot Study

Groupe Hospitalier de la Region de Mulhouse et Sud Alsace1 site in 1 country68 target enrollmentJanuary 26, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes Mellitus, Type I
Sponsor
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
Enrollment
68
Locations
1
Primary Endpoint
The DIAPASON questionnaire
Status
Completed
Last Updated
5 months ago

Overview

Brief Summary

The needs of children and teens with type 1 diabetes are very specific and different from the adults with type 1 diabetes. Many organizations such as the World Health Organization or the International Society for Pediatric and Adolescent Diabetes, recommend a patient therapeutic education when it comes to children with type 1 diabetes.

This study aims to evaluate the impact of a therapeutic education program on theoretical knowledge of the disease and also on quality of life, on biological and clinical indicators.

Detailed Description

Structuring a therapeutic education program for patients with a chronic disease was the initiative of the French High Health Authority in June 2007. The Prevention and Care of Pediatric Obesity and Pediatric Diabetes Organization of Mulhouse is a partner of the Mulhouse Hospital. Besides the usual care given at the hospital of Mulhouse for patients with a type 1 diabetes, both organizations also provide therapeutic education to these patients. Each therapeutic education program is organized according to the patient's age. They can also be organized in a group or individually. The aim of the therapeutic education is to help the young patients to cope with diabetes in their daily activities. Therapeutic education is known to bring good results for patients with diabetes, but there is no studies in France for children and teens with a type 1 diabetes.

Registry
clinicaltrials.gov
Start Date
January 26, 2016
End Date
March 20, 2017
Last Updated
5 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Enrollment between January 15 to March 15, 2016
  • Insulin-dependent type 1 Diabetes
  • Treatment received at the Hospital of Mulhouse, France

Exclusion Criteria

  • Opposition to study participation
  • Behavioral issues
  • Uncontrolled psychological issue

Outcomes

Primary Outcomes

The DIAPASON questionnaire

Time Frame: The outcome will be the change of the answers to the questionnaire from enrollment to the end of the study, ten months later.

50 item questionnaire that evaluates the patient's theoretical knowledge of the type 1 diabetes disease. Questionnaire submitted to patients and a parent.

Secondary Outcomes

  • Evolution of glycated hemoglobin(Throughout the study : on the enrollment day, 2 months after enrollment, 4 months after enrollment, 6 months after enrollment, 8 months after enrollment and 10 months after enrollment which is the end of the study participation)
  • Occurrence of severe hypoglycemic events(Throughout the study : on the enrollment day, 2 months after enrollment, 4 months after enrollment, 6 months after enrollment, 8 months after enrollment and 10 months after enrollment which is the end of the study participation)
  • Psychological indicators(On day 1, at enrollment, and 10months later, at the end of the study participation)
  • Need for care indicators(Throughout the study : on the enrollment day, 2 months after enrollment, 4 months after enrollment, 6 months after enrollment, 8 months after enrollment and 10 months after enrollment which is the end of the study participation)
  • Occurrence of ketoacidosis events(Throughout the study : on the enrollment day, 2 months after enrollment, 4 months after enrollment, 6 months after enrollment, 8 months after enrollment and 10 months after enrollment which is the end of the study participation)
  • Behavioral indicators(Throughout the study : on the enrollment day, 2 months after enrollment, 4 months after enrollment, 6 months after enrollment, 8 months after enrollment and 10 months after enrollment which is the end of the study participation)

Study Sites (1)

Loading locations...

Similar Trials